Minireviews
Copyright ©The Author(s) 2021.
World J Clin Oncol. Dec 24, 2021; 12(12): 1182-1192
Published online Dec 24, 2021. doi: 10.5306/wjco.v12.i12.1182
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 A schematic diagram showing programed death-1/ programed death ligand-1 interaction with immune cells in cancer. PD-1: Programed death-1; PD-LI: Programed death ligand-1.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 A schematic diagram showing cytotoxic T lymphocyte–associated antigen 4-2/B7-1-B7-2 interaction with immune cells in cancer. CTLA-4: Cytotoxic T lymphocyte–associated antigen 4.